Literature DB >> 14708732

Developmentally regulated expression of Survivin in human pancreatic islets.

C Liggins1, D J Orlicky, L A Bloomquist, Roberto Gianani.   

Abstract

Islet cell apoptosis plays a role in both normal development of the endocrine pancreas and in the pathogenesis of Type I and Type II diabetes. The molecular mechanisms regulating islet cell death and survival in both normal and pathological situations are still not completely elucidated. The inhibitor of apoptosis protein (IAP) Survivin has an anti-apoptotic function mediated by several mechanisms; these include inhibiting caspase 3 and caspase 7. Survivin expression has been reported in human fetal islets and it may play a role in pancreatic remodeling and islet homeostasis. However, there are no data concerning either its expression in neonate or adult islets or its expression in any specific subtype of islet cells. We identified Survivin expression by immunohistochemistry in alpha cells and beta islet cells of 5/5 fetal pancreases. In contrast, fetal delta cells failed to demonstrate any detectable level of Survivin expression. Survivin expression was subsequently lost in the beta cells but not the alpha cells of 5/5 newborns and 5/5 adult subjects. Neonatal and adult delta cells maintained the lack of Survivin expression seen in fetal islets. These data show that different subtypes of islet cells differ in their pattern of Survivin expression. Furthermore, expression of Survivin in the beta cells is developmentally regulated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708732     DOI: 10.1007/s10024-003-2014-0

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  9 in total

Review 1.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

2.  Prolactin-stimulated survivin induction is required for beta cell mass expansion during pregnancy in mice.

Authors:  Yili Xu; Xiaojing Wang; Li Gao; Jiayu Zhu; Hui Zhang; Houxia Shi; Minna Woo; Xiaohong Wu
Journal:  Diabetologia       Date:  2015-06-23       Impact factor: 10.122

3.  Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.

Authors:  Klaus L Prenzel; Ute Warnecke-Eberz; Jan Brabender; Stephan E Baldus; Elfriede Bollschweiler; Christian A Gutschow; Uta Drebber; Arnulf H Hoelscher; Paul M Schneider
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

4.  Perinatal survivin is essential for the establishment of pancreatic beta cell mass in mice.

Authors:  X Wu; L Wang; S Schroer; D Choi; P Chen; H Okada; M Woo
Journal:  Diabetologia       Date:  2009-07-31       Impact factor: 10.122

5.  Dimorphic histopathology of long-standing childhood-onset diabetes.

Authors:  R Gianani; M Campbell-Thompson; S A Sarkar; C Wasserfall; A Pugliese; J M Solis; S C Kent; B J Hering; E West; A Steck; S Bonner-Weir; M A Atkinson; K Coppieters; M von Herrath; G S Eisenbarth
Journal:  Diabetologia       Date:  2010-01-09       Impact factor: 10.122

6.  Transcriptomic and Quantitative Proteomic Profiling Reveals Signaling Pathways Critical for Pancreatic Islet Maturation.

Authors:  Yu-Chin Lien; Kyoung-Jae Won; Rebecca A Simmons
Journal:  Endocrinology       Date:  2020-12-01       Impact factor: 4.736

7.  Survivin is required for beta-cell mass expansion in the pancreatic duct-ligated mouse model.

Authors:  Xiaohong Wu; Qinfeng Zhang; Xiaojing Wang; Jiayu Zhu; Kuangfeng Xu; Hitoshi Okada; Rennian Wang; Minna Woo
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

8.  Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.

Authors:  Zhouxun Chen; Naxin Liu; Guanbao Zhu; Henning Dralle; Cuong Hoang-Vu
Journal:  Int J Mol Med       Date:  2012-06-28       Impact factor: 4.101

Review 9.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.